Position in LLY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,542,467
+$381,718 QoQ
Shares Held
1,286
+1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#2,743
of 4,605 holders
Holding Since
Sep 2020
24 quarters on record
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRAPHAGEN INVESTMENT ADVISORS LLC holds $8,468,712 across 7 Drug Manufacturers - General names. LLY ranks #3 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,821 | $2,494,239 | |
| 2 | ABBV |
AbbVie Inc.
|
9,472 | $2,383,534 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
1,286 | $1,542,467 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,280 | $806,980 | |
| 5 | PFE |
Pfizer Inc
|
22,620 | $544,689 | |
| 6 | AMGN |
Amgen Inc
|
1,367 | $495,018 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,502 | $201,785 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,542,467 | 1,286 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,160,749 | 1,262 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,314,333 | 1,223 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $938,490 | 1,230 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $969,735 | 1,244 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,049,731 | 1,271 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $983,528 | 1,274 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,133,117 | 1,279 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,145,305 | 1,265 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $1,249,403 | 1,606 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $887,787 | 1,523 | Shares | Sole | 2024-06-17 | |
| 2023-09-30 | $759,501 | 1,414 | Shares | Sole | 2024-06-17 | |
| 2023-06-30 | $683,772 | 1,458 | Shares | Sole | 2024-06-17 | |
| 2023-03-31 | $405,579 | 1,181 | Shares | Sole | 2024-06-17 | |
| 2022-12-31 | $416,691 | 1,139 | Shares | Sole | 2024-06-17 | |
| 2022-09-30 | $207,914 | 643 | Shares | Sole | 2024-06-17 | |
| 2022-06-30 | $2,616,211 | 8,069 | Shares | Sole | 2024-06-17 | |
| 2022-03-31 | $2,455,622 | 8,575 | Shares | Sole | 2024-06-17 | |
| 2021-12-31 | $2,469,683 | 8,941 | Shares | Sole | 2024-06-17 | |
| 2021-09-30 | $1,909,397 | 8,264 | Shares | Sole | 2024-06-17 | |
| 2021-06-30 | $1,855,439 | 8,084 | Shares | Sole | 2024-06-17 | |
| 2021-03-31 | $1,526,879 | 8,173 | Shares | Sole | 2024-06-17 | |
| 2020-12-31 | $1,391,916 | 8,244 | Shares | Sole | 2024-06-17 | |
| 2020-09-30 | $799,308 | 5,400 | Shares | Sole | 2024-06-17 | |
| No filing history on record for this holder in this stock. | ||||||